News | December 20, 2022
Guerison to set up footprints in India’s ophthalmology market
Global pharmaceutical company having a surgical business concept incepted in Dubai
Global pharmaceutical company having a surgical business concept incepted in Dubai
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
_256_384.png)
Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.
The joint venture will help both the parties to further develop the high-margin service business
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
The product is expected to be launched by Q4 FY23.
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
Subscribe To Our Newsletter & Stay Updated
